Recente publicaties

Effectiveness of bi-monthly long-acting injectable cabotegravir and rilpivirine as maintenance treatment for HIV-1 in the Netherlands: results from the Dutch ATHENA national observational cohort
Jongen, VW, Wit FWNM, Boyd A, van Eeden A, Brouwer AE, Soetekouw R, El Moussaoui R, Stalenhoef J, Sigaloff KCE, Mudrikova T, Gisolf J, Burger D, Wensing AMJ, van der Valk M; ATHENA National Observational HIV Cohort
HIV Medicine. 2025 Jan; doi.org/10.1016/S2352-3018(24)00269-8

Hepatitis C Treatment and Behavioral Risk Among Men Who Have Sex With Men With HIV: Comparing Interferon and Direct-Acting Antiviral Eras
Hage K, Boyd A, van Santen DK, Brinkman K, Arends J, Lauw F, Rijnders B, van Eeden A, van der Valk M, Newsum A, Matser A, Schinkel J, Prins M
J Acquir Immune Defic Syndr. 2025  Jan; doi.org/10.1097/QAI.0000000000003550

Unsuccessful direct acting antiviral hepatitis C treatment among people with HIV: Findings from an international cohort
Harney BL, Sacks-Davis R, van Santen DK, Stewart AC, Matthews GV, Carson JM, Klein MB, Lacombe K, Wittkop L, Salmon D, Leleux O, Merchadou L, van der Valk M, Smit C, Prins M, Boyd A, Berenguer J, Jarrin I, Rauch A, Hellard ME, Doyle JS
Liver Int. 2025 Jan; doi.org/10.1111/liv.16203

Harmonisation of alcohol use data and mortality across a multi-national HIV cohort collaboration
Ingle SM, Trickey A, Lankina A, McGinnis KA, Justice A, Cavassini M, d' Arminio Monforte A, van Sighem A, Gill MJ, Crane HM, Obel N, Jarrin I, Wallner E, Guest J, Silverberg MJ, Vourli G, Wittkop L, Sterling TR, Satre DD, Burkholder GA, Costagliola D, Sterne JAC
Alcohol: Clinical and Experimental Research. 2025 Jan; doi.org/10.1111/acer.15522

A Biomarker Profile Reflective of Preserved Thymic Function Is Associated With Reduced Comorbidities in Aging People With HIV: An AGEhIV Cohort Analysis
Vanbellinghen MC, Boyd A, Kootstra NA, Schim van der Loeff MF, van der Valk M, Reiss P; AGEhIV Cohort study group
the Journal of Infectious Diseases. 2024 Dec; doi.org/10.1093/infdis/jiae603

HIV prevention and missed opportunities among people with recently acquired HIV infection: Α protocol for a systematic review
Karakosta A, Ruiz-Burga E, Tariq S, Touloumi G, Nicholls EJ, Pantazis N, Jarrin I, Van der Valk M, Sabin C, Mussini C, Meyer L, Volny Anne A, Carlander C, Grabar S, Wittkop L, Spire B, Gill J, Porter K, Burns F, CASCADE Collaboration
PloS one. 2024 Dec; doi.org/10.1371/journal.pone.0295462

Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration
Tusch E, Ryom L, Pelchen-Matthews A, Mocroft A, Elbirt D, Oprea C, Günthard HF, Staehelin C, Zangerle R, Suarez I, Vehreschild JJ, Wit F, Menozzi M, d’Arminio Monforte A, Spagnuolo V, Pradier C, Carlander C, Suanzes P, Wasmuth JC, Carr A, Petoumenos K, Borgans F, Bonnet F, De Wit S, El-Sadr W, Neesgaard B, Jaschinski N, Greenberg L, Hosein SR, Gallant J, Vannappagari V, Young L, Sabin C, Lundgren J, Peters L, Reekie J; D:A:D cohort study; RESPOND cohort study
Clinical Infectious Diseases. 2024 Nov; doi.org/10.1093/cid/ciae228

HIV replication and tuberculosis risk among people living with HIV in Europe: A multicohort analysis, 1983-2015
Atkinson A, Kraus D, Banholzer N, Miro JM, Reiss P, Kirk O, Mussini C, Morlat P, Podlekareva D, Grant AD, Sabin C, van der Valk M, Le Moing V, Meyer L, Seng R, Castagna A, Obel N, Antoniadou A, Salmon D, Zwahlen M, Egger M, de Wit S, Furrer H, Fenner L; Opportunistic Infections Project Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
PLoS One. 2024 Oct; doi.org/10.1371/journal.pone.0312035

Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort study
Oomen PGA, Wit FWNM, Brinkman K, Vrouenraets SME, Mudrikova T, van Welzen BJ, van der Valk M; ATHENA National Observational Cohort Study
The Lancet HIV. 2024 Sept; doi.org/10.1016/S2352-3018(24)00150-4

Care interruptions and mortality among adults in Europe and North America
Trickey A, Zhang L, Rentsch CT, Pantazis N, Izquierdo R, Antinori A, Leierer G, Burkholder G, Cavassini M, Palacio-Vieira J, Gill MJ, Teira R, Stephan C, Obel N, Vehreschild JJ, Sterling TR, van der Valk M, Bonnet F, Crane HM, Silverberg MJ, Ingle SM, Sterne JAC; Antiretroviral Therapy Cohort Collaboration (ART-CC)
AIDS. 2024 Aug; doi.org/10.1097/QAD.0000000000003924

Assessing the HIV care continuum among transgender women during 11 years of follow-up: results from the Netherlands’ ATHENA observational cohort
Jongen VW, Daans C, van Sighem A, Schim van der Loeff M, Hage K, Welling C, von Vaupel-Klein A, den Heijer M, Peters EJG, van der Valk M, Reiss P, Prins M, Hoornenborg E, the ATHENA observational HIV cohort
Journal of the International Aids Society. 2024 Aug; doi.org/10.1002/jia2.26317

Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration
Pantazis N, Sabin CA, Grabar S, van der Valk M, Jarrin I, van Sighem A, Meyer L, Carlander C, Gill J, Volny-Anne A, Spire B, Tariq S, Burns F, Costagliola D, Ruiz-Burga E, Touloumi G, Porter K, CASCADE Collaboration
The Lancet HIV. 2024 Aug; doi.org/10.1016/S2352-3018(24)00183-8

Similar Limited Protection Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Infection in Vaccinated Individuals With HIV and Comparable Controls
Verburgh ML, Boyd A, Schim van der Loeff MF, Bakker M, Wit FWNM, van der Valk M, Grobben M, van Pul L, Tejjani K, van Rijswijk J, van Gils MJ, Kootstra NA, van der Hoek L, Reiss P; AGEhIV Cohort Study
Open Forum Infectious Diseases. 2024 July; doi.org/10.1093/ofid/ofae380

Discrimination of the Veterans Aging Cohort Study Index 2.0 for predicting cause-specific mortality among persons with HIV in Europe and North America
Ambia J, Ingle SM, McGinnis K, Pantazis N, Silverberg MJ, Wittkop L, Kusejko K, Crane H, van Sighem A, Sarcletti M, Cozzi-Lepri A, Domingo P, Jarrin I, Wyen C, Hessamfar M, Zhang L, Cavassini M, Berenguer J, Sterling TR, Reiss P, Abgrall S, Gill MJ, Justice A, Sterne JAC, Trickey A
Open Forum Infectious Diseases. 2024 July; doi.org/10.1093/ofid/ofae333

Sources of Human Immunodeficiency Virus Infections Among Men Who Have Sex With Men With a Migration Background: A Viral Phylogenetic Case Study in Amsterdam, The Netherlands
Blenkinsop A, Pantazis N, Kostaki EG, Sofocleous L, van Sighem A, Bezemer D, van de Laar T, van der Valk M, Reiss P, de Bree G, Ratmann O, for the HIV Transmission Elimination Amsterdam (H-team) Consortium
the Journal of Infectious Diseases. 2024 July; doi.org/10.1093/infdis/jiae267

First-line antiretroviral therapy initiation for newly diagnosed people with HIV in the Netherlands: A retrospective analysis from 2016 to 2020
Oosterhof P, Wit FWNM, van Luien M, van der Valk M, Brinkman K, Burger DM
PLoS One. 2024 July; doi.org/10.1371/journal.pone.0307963

COVID-19 epidemiology and performance of the WHO clinical algorithm to diagnose COVID-19 in people with HIV from Ukraine
Vasylyev M, Buhiichyk V, Buhiichyck N, Groenendijk A, Ben I, Ostapiuk L, Sluzhynska M, Bierman WFW, van Kampen JJA, Wit FWNM, Reiss P, Rijnders BJA, Sluzhynska O, Rokx
International Journal of STD & AIDS. 2024 June; doi.org/10.1177/09564624241231016

De‐simplifying antiretroviral therapy from a single‐tablet to a two‐tablet regimen: Acceptance, patient‐reported outcomes, and cost savings in a multicentre study
Oosterhof P, De Zoete BGJA, Vanhommerig JW, Langebeek N, Gisolf EH, Van Hulzen AGW, Lammers AJJ, Weijsenfeld AM, Van der Valk M, Grintjes K, Van Crevel R, Van Luin M, Brinkman K, Burger DM
HIV Medicine. 2024 May 7; doi.org/10.1111/hiv.13655

Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts
Byonanebye DM, Polizzotto MN, Maltez F, Rauch A, Grabmeier-Pfistershammer K, Wit F, De Wit S, Castagna A, d'Arminio Monforte A, Mussini C, Wasmuth JC, Fontas E, Abela I, Sarcletti M, Bansi-Matharu L, Jaschinski N, Peters L, Hosein SR, Vannappagari V, Cohen C, Bissio E, Mocroft A, Law M, Ryom L, Petoumenos K
Lancet HIV. 2024 April 12; doi.org/10.1016/S2352-3018(23)00328-4 

Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration
Tusch E, Ryom L, Pelchen-Matthews A, Mocroft A, Elbirt D, Oprea C, Günthard HF, Staehelin C, Zangerle R, Suarez I, Vehreschild JJ, Wit F, Menozzi M, D'Arminio Monforte A, Spagnuolo V, Pradier C, Carlander C, Suanzes P, Wasmuth JC, Carr A, Petoumenos K, Borgans F, Bonnet F, De Wit S, El-Sadr W, Neesgaard B, Jaschinski N, Greenberg L, Hosein SR, Gallant J, Vannappagari V, Young L, Sabin C, Lundgren J, Peters L, Reekie J, D:A:D cohort study, RESPOND cohort study
Clinical Infectious Diseases. 2024 April 26; doi.org/10.1093/cid/ciae228

Targeted Screening for Viral Hepatitis Among Various Ethnic Groups in Amsterdam, the Netherlands
Van Dijk AM, Isfordink C, Boyd A, Galenkamp H, Schinkel J, Prins M, Takkenberg RB, Holleboom O, Van Der Valk M
Hepatitis Monthly. 2024 April 14; doi.org/10.5812/hepatmon-136838

Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies
Vos WAJW, Vadaq N, Matzaraki V, Otten T, Groenendijk AL, Blaauw MJT, van Eekeren LE, Brinkman K, de Mast Q, Riksen NP, Stalenhoef AFH, van Lunzen J, van der Ven AJAM, Blok WL, Stalenhoef JE
Viruses. 2024 April; doi.org/10.3390/v16040582

Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV
Jaschinski N, Greenberg L, Neesgaard B, Miró JM, Grabmeier-Pfistershammer K, Wandeler G, Smith C, De Wit S, Wit F, Pelchen-Matthews A, Mussini C, Castagna A, Pradier C, d'Arminio Monforte A, Vehreschild J, Sönnerborg A, Anne AV, Carr A, Bansi-Matharu L, Lundgren J, Garges H, Rogatto F, Zangerle R, Günthard HF, Rasmussen LD, Nescoi C, Van Der Valk M, Menozzi M, Muccini C, Mocroft A, Peters L, Ryom L; RESPOND Study Group.
AIDS. 2024 March; doi.org/10.1097/QAD.0000000000003373

Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort Study
Vasylyev M, Wit FWNM, Jordans CCE, Soetekouw R, Van Lelyveld SFL, Kootstra GJ, Delsing CE, Ammerlaan HSM, Van Kasteren MEE, Brouwer AE, Leyten EMS, Claassen MAA, Hassing RJ, Den Hollander JG, Van den Berge M, Roukens AHE, Bierman WFW, Groeneveld PHP, Lowe SH, Van Welzen BJ, Richel O, Nellen JF, Van den Berk GEL, Van der Valk M, Rijnders BJA, Rokx C
Open Forum Infectious Diseases; 2024 March 18; doi.org/10.1093/ofid/ofae160

Heavy antiretroviral exposure and exhausted/limited antiretroviral options: predictors and clinical outcomes
Mocroft A, Pelchen-Matthews A, Hoy J, Llibre JM, Neesgaard B, Jaschinski N, Domingo P, Rasmussen LD, Günthard HF, Surial B, Öllinger A, Knappik M, de Wit S, Wit F, Mussini C, Vehreschild J, Monforte AD, Sonnerborg A, Castagna A, Anne AV, Vannappagari V, Cohen C, Greaves W, Wasmuth JC, Spagnuolo V, Ryom L; for the RESPOND cohort collaboration.
AIDS. 2024 March 15; 10.1097/QAD.0000000000003798

Virological failure after switch to long-acting cabotegravir and rilpivirine injectable therapy: an in-depth analysis
Sacks-Davis R, van Santen DK, Boyd A, Young J, Stewart A, Doyle JS, Rauch A, Mugglin C, Klein M, van der Valk M, Smit C, Jarrin I, Berenguer J, Lacombe K, Requena MB, Wittkop L, Leleux O, Bonnet F, Salmon D, Matthews GV, Guy R, Martin NK, Spelman T, Prins M, Stoove M, Hellard M; InCHEHC Collaboration
The Lancet HIV. 2024 Feb; doi.org/10.1016/S2352-3018(23)00267-9

Screening for tuberculosis infection and effectiveness of preventive treatment among people with HIV in low-incidence settings
Van Geuns D, Arts RJW, De Vries G, Wit FWNM, Degtyareva SY, Brown J, Pareek M, Lipman M, Van Crevel R
AIDS. 2024 February 1; 10.1097/QAD.0000000000003747

Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe
Patmore LA, Van Eekhout KMA, Buti M, Koc ÖM, Agarwal K, De Knegt RJ, Janssen HLA, Van der Valk M, Lieveld FI, Hansen BE, Kramer M, De Bruijne J, Claassen MAA, Smit C, De Man RA, Takkenberg B †, Carey I †, Sonneveld MJ †, the HARP study group and HepNed
Journal of Hepatology. 2024 February; doi.org/10.1016/j.jhep.2023.10.019

All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019
Requena MB, Protopopescu C, Stewart AC, Van Santen DK, Klein MB, Jarrin I, Berenguer J, Wittkop L, Salmon D, Rauch A, Prins M, Van der Valk M, Sacks-Davis R, Hellard ME, Carrieri P, Lacombe K; InCHEHC Collaboration
International Journal of Drug Policy. 2024 February; doi.org/10.1016/j.drugpo.2023.104311

Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies
Sacks-Davis R, Van Santen DK, Boyd A, Young J, Stewart A, Doyle JS, Rauch A, Mugglin C, Klein M, Van der Valk M, Smit C, Jarrin I, Berenguer J, Lacombe K, Requena MB, Wittkop L, Leleux O, Bonnet F, Salmon D, Matthews GV, Guy R, Martin NK, Spelman T, Prins M, Stoove M, Hellard M; InCHEHC Collaboration
Lancet HIV. 2024 Feb; doi.org/10.1016/S2352-3018(23)00267-9

Socio‐economic factors associated with loss to follow‐up among individuals with HCV: A Dutch nationwide cross‐sectional study
van Dijk M, Boyd A, Brakenhoff SM, Isfordink CJ, van Zoest RA, Verhagen MD, de Knegt RJ, Drenth JPH, van der Valk M; HepNed study group
Liver Int. 2024 Jan; doi.org/10.1111/liv.15729

Recent data on the role of antiretroviral therapy in weight gain and obesity in persons living with HIV
Capeau J, Lagathu C, Béréziat, V
Current Opinion in HIV and AIDS. 2024 Jan; doi.org/10.1097/COH.0000000000000833

Sources of HIV infections among MSM with a migration background: a viral phylogenetic case study in Amsterdam, the Netherlands
Blenkinsop A, Pantazis N, Kostaki EG, Sofocleous L, van Sighem A, Bezemer D, van de Laar T, van der Valk M, Reiss P, de Bree G, Ratmann O
arXiv. 2024 Jan; doi.org/10.48550/arXiv.2401.08308